7,48 €
1,54 % vorgestern
L&S, 24. Oktober, 22:55 Uhr
ISIN
US53222K2050
Symbol
LFVN
Berichte

LifeVantage Corporation Aktie News

Neutral
GlobeNewsWire
5 Tage alt
SALT LAKE CITY, Oct. 21, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its first quarter ended September 30, 2025, after the stock market closes on Tuesday, November 4, 2025. The Company will hold a c...
Neutral
GlobeNewsWire
13 Tage alt
SALT LAKE CITY, Oct. 13, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer will participate in the LD Micro Main Event XIX, to be held October 19-21, 2025 in San Diego, CA.
Neutral
GlobeNewsWire
24 Tage alt
SALT LAKE CITY, Oct. 02, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the closing of its previously announced acquisition of LoveBiome, a pioneering direct sales company dedicated to comprehensive microbiome care and wellness solutions. Under...
Neutral
GlobeNewsWire
etwa ein Monat alt
SALT LAKE CITY, Sept. 22, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the Lytham Partners Fall 2025 Investor Conference, to b...
Negativ
Seeking Alpha
etwa 2 Monate alt
LifeVantage reported disappointing Q4/FY2025 results as domestic sales of the company's much-touted MindBody GLP-1 System came in below expectations. Following an impressive start, MindBody GLP-1 System sales have largely failed to ride the coattails of blockbuster weight-loss drugs like Wegovy and Zepbound. The company also issued FY2026 guidance below consensus expectations. At the mid-point ...
Neutral
Seeking Alpha
etwa 2 Monate alt
LifeVantage Corporation (NASDAQ:LFVN ) Q4 2025 Earnings Call September 4, 2025 4:30 PM EDT Company Participants Steven Fife - President, CEO & Director Carl Aure - Chief Financial Officer Conference Call Participants Reed Anderson - ICR Inc. Douglas Lane - Water Tower Research LLC Presentation Operator Good day, ladies and gentlemen. Thank you for standing by.
Neutral
GlobeNewsWire
etwa 2 Monate alt
SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth quarter and full fiscal year ended June 30, 2025.
Neutral
GlobeNewsWire
etwa 2 Monate alt
Strategic acquisition expands network of Consultants, and strengthens LifeVantage's Activation differentiation in the rapidly growing gut health market Strategic acquisition expands network of Consultants, and strengthens LifeVantage's Activation differentiation in the rapidly growing gut health market

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen